金伟,卢振兴南昌市第三医院心内二科,江西南昌 330006
不同剂量叶酸联合降压药治疗H型高血压的临床对比分析
金伟,卢振兴
南昌市第三医院心内二科,江西南昌330006
目的 对比分析不同剂量叶酸联合降压药治疗H型高血压的临床疗效。方法 整群选取该院2014年7月—2016年1月收治的156例H型高血压患者,随机分为3组,各52例。A组口服小剂量(0.8 mg)叶酸片+马来酸依那普利片,B组口服大剂量叶酸片(5 mg)+马来酸依那普利片,C组仅予马来酸依那普利片治疗。比较3组治疗效果。结果A组、B组治疗后收缩压、舒张压、Hcy水平分别为(119.86±8.56)mmHg、(73.41±7.89)mmHg、(12.25±5.96)μmol/L和(120.85± 9.04)mmHg、(75.02±9.96)mmHg、(11.89±6.14)μmol/L,均明显低于C组的(134.33±11.25)mmHg、(84.27±6.50)mmHg、(16.77± 4.92)μmol/L,(P<0.01),A组、B组间比较,差异无统计学意义(P>0.05)。结论 叶酸联合降压药治疗H型高血压能明显改善血压与Hcy水平,小剂量用药即可达到较好效果。期待大规模临床实验进一步研究探讨。
叶酸;依那普利;H型高血压;同型半胱氨酸
[Abstract]Objective To contrastanalysis of different doses of folic acid with antihypertensive drug therapy H the clinical curative effect of high blood pressure.Methods Group selection 156 patients with H hypertension patients in our hospital from July 2014 to January 2016 were selected as the research objects and were randomly divided into three groups,52 cases in each group.Patients in group A were taken a small dose of folic acid(0.8 mg)+enalapril maleatetablets orally,and Patients in group B a large dose of folic acid(5 mg)+enalapril maleatetablets orally,while patients in group C were only given enalapril maleatetablets.The clinical effects among the three groups were compared.Results After treatment,systolic pressure,diastolic pressure and the level of Hcyobviously of patients in group A,group B is respectively(119.86±8.56)mmHg, (73.41±7.89)mmHg、(12.25±5.96)μmol/L and(120.85±9.04)mmHg、(75.02±9.96)mmHg、(11.89±6.14)μmol/L,which decreased significantly compared with(134.33±11.25)mmHg、(84.27±6.50)mmHg、(16.77±4.92)μmol/L in group C(P<0.01), Group A compared with group B,there was no statistical difference(P>0.05).Conclusion Folic acid in combination with the antihypertensive drug treatment H high blood pressure can improve blood pressure and the level of Hcyobviously,and small dose of medication can achieve good curative effect.Looking forward to large-scale clinical trials to further research.
[Key words]Folicacid;Enalapril;H hypertension;Homocysteine
目前中国有超过1.5亿的原发性高血压患者,其中75%左右为H型高血压,即伴有高同型半胱氨酸血症(HHcy)的原发性高血压。依那普利为常用降压药物,叶酸则在降低血清同型半胱氨酸(Hcy)水平中发挥着重要作用,为进一步探讨两药联合治疗的协同作用,该研究对该院2014年7月—2016年1月收治的156例H型高血压患者分别采用不同剂量叶酸和依那普利治疗,现报道如下。
1.1一般资料
整群选取该院收治的156例H型高血压患者,纳入标准:①符合《中国高血压防治指南》(2010年版)[1]诊断标准,Hcy≥10 μmol/L;②原发性高血压;③1级、2级高血压;④患者签订知情同意书。排除标准:①继发性高血压;②高血压急症、严重心肝肾功能不全、严重贫血及恶性肿瘤者;……